Clinical evaluation of Bilvadileha in the management of irritable bowel syndrome

Irritable bowel syndrome (IBS) is one of the most common conditions encountered in clinical practice but one of the least well understood. Symptoms of this disorder are chronic, sometimes severe and often respond poorly to treatment, resulting in reduced quality of life. There is no specific test fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiwari, Ramanand, Pandya, Darshana H., Baghel, Madhav Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968698/
https://www.ncbi.nlm.nih.gov/pubmed/24696573
http://dx.doi.org/10.4103/0974-8520.127717
_version_ 1782309193151152128
author Tiwari, Ramanand
Pandya, Darshana H.
Baghel, Madhav Singh
author_facet Tiwari, Ramanand
Pandya, Darshana H.
Baghel, Madhav Singh
author_sort Tiwari, Ramanand
collection PubMed
description Irritable bowel syndrome (IBS) is one of the most common conditions encountered in clinical practice but one of the least well understood. Symptoms of this disorder are chronic, sometimes severe and often respond poorly to treatment, resulting in reduced quality of life. There is no specific test for IBS, although diagnostic tests may be performed to rule out other problems. In present clinical trial 51 patients of IBS were registered out of which 46 patients completed the treatment. Bilvadileha was administered for the duration of 12 weeks. The therapy showed statistically significant improvement in all the clinical features of IBS as well as in the IBS severity score.
format Online
Article
Text
id pubmed-3968698
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-39686982014-04-02 Clinical evaluation of Bilvadileha in the management of irritable bowel syndrome Tiwari, Ramanand Pandya, Darshana H. Baghel, Madhav Singh Ayu Clinical Research Irritable bowel syndrome (IBS) is one of the most common conditions encountered in clinical practice but one of the least well understood. Symptoms of this disorder are chronic, sometimes severe and often respond poorly to treatment, resulting in reduced quality of life. There is no specific test for IBS, although diagnostic tests may be performed to rule out other problems. In present clinical trial 51 patients of IBS were registered out of which 46 patients completed the treatment. Bilvadileha was administered for the duration of 12 weeks. The therapy showed statistically significant improvement in all the clinical features of IBS as well as in the IBS severity score. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3968698/ /pubmed/24696573 http://dx.doi.org/10.4103/0974-8520.127717 Text en Copyright: © AYU (An International Quarterly Journal of Research in Ayurveda) http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Research
Tiwari, Ramanand
Pandya, Darshana H.
Baghel, Madhav Singh
Clinical evaluation of Bilvadileha in the management of irritable bowel syndrome
title Clinical evaluation of Bilvadileha in the management of irritable bowel syndrome
title_full Clinical evaluation of Bilvadileha in the management of irritable bowel syndrome
title_fullStr Clinical evaluation of Bilvadileha in the management of irritable bowel syndrome
title_full_unstemmed Clinical evaluation of Bilvadileha in the management of irritable bowel syndrome
title_short Clinical evaluation of Bilvadileha in the management of irritable bowel syndrome
title_sort clinical evaluation of bilvadileha in the management of irritable bowel syndrome
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968698/
https://www.ncbi.nlm.nih.gov/pubmed/24696573
http://dx.doi.org/10.4103/0974-8520.127717
work_keys_str_mv AT tiwariramanand clinicalevaluationofbilvadilehainthemanagementofirritablebowelsyndrome
AT pandyadarshanah clinicalevaluationofbilvadilehainthemanagementofirritablebowelsyndrome
AT baghelmadhavsingh clinicalevaluationofbilvadilehainthemanagementofirritablebowelsyndrome

Ejemplares similares